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Disorders of gait and balance are common in medicine and often lead to referral for
neurologic evaluation. Because the maintenance of balance and normal gait are
mediated by complex neurologic pathways as well as musculoskeletal, metabolic,
and behavioral considerations, the list of possible contributing causes is very large.
Much of the time, the history and neurologic examination reveal the underlying cause or
causes. There are instances, however, when there are limited neurologic ﬁndings, as well
as no structural abnormalities on brain or spine magnetic resonance imaging studies to
explain the imbalance or gait difﬁculty. In this article, selected disorders that may be
overlooked in the neurologic examination and imaging studies are reviewed. Possible
causes of imbalance include occult drug-induced ataxia, autoimmune ataxia, ataxia
associated with tremor, bilateral vestibular hypofunction, and spastic or dystonic gait
disorders with normal imaging.

Disorders of gait and balance are among the more common
clinical complaints, particularly among older patients.1 Because so many medical and neurologic conditions can inﬂuence balance and ambulation, a thorough evaluation is often
necessary. Thus, a neurologic examination, brain imaging,
and sometimes electrophysiologic studies are done to identify contributing causes and to assess and to try to reduce the
risk of falling.2
In many instances, the history and examination reveal the
likely causes. In other cases, brain magnetic resonance imaging (MRI), spine MRI studies, electromyography, and nerve
conduction studies are necessary to conﬁrm the likely mechanism. In some instances, even after a thorough neurologic
history and examination and extensive imaging studies the
cause of the imbalance or gait disturbance remains unclear.
Commonly, a multitude of contributing factors separately
contribute to disturbance of gait or balance. Other times,
no convincing cause can be determined. ►Table 1 lists disorders that may present with gait ataxia.
This review will focus on selected causes of imbalance or
disturbed gait that may be overlooked even in the face of a
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thorough neurologic, imaging and electrophysiological
evaluation.

Drug-Induced Gait Ataxia
Ataxia is a common manifestation of many drugs and toxins.
For instance, most of the antiepileptic agents have ataxia as a
relatively common acute adverse event; phenytoin, phenobarbital, and carbamazepine, in particular, may also have a
dose-related adverse effect on balance.3
However, there are several agents that warrant discussion
as it might not be obvious that the drug is the causative agent
primarily because the onset of gait disturbance may be quite
delayed, mimicking a degenerative condition.

Lithium Ataxia
Lithium is an agent primarily used for mood stabilization in
bipolar illness. Because of the narrow therapeutic window
and need for blood monitoring, it is less commonly used in
favor of agents such as quetiapine and lamotrigine. However,
many patients are still chronically receiving treatment with
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Table 1 Disorders that may present with gait ataxia
Toxins/drugs

Infectious

Metabolic

Basal ganglia

Genetic

Autoimmune

Ethanol

Creutzfeldt-Jakob
disease

B12

Early Parkinson’s disease

Dominant

Generalized
anxiety disorder

Phenytoin

JC virus

Wernicke’s
encephalopathy

Progressive
supranuclear palsy

Recessive

Gluten sensitivity

Lithium

Viral

Multiple system atrophy

Mitochondrial

Hypothyroidism

Amiodarone

Postviral

Other

Corticobasal
degeneration

X-linked

Hashimoto’s
encephalopathy

Isoniazid

Whipple’s

Segawa’s disease

DNA repair

Paraneoplastic

Spinal arteriovenous
malformation

Platens

Structural

Cyclosporine

Tumor

Valproic acid

Demyelinating

Miller-Fisher syndrome

Vascular
Abscess
Sarcoid
Hydrocephalus

lithium. Ataxia may develop insidiously after many years on
the drug, even though the patient has normal serum levels
and lithium tremor may be absent.4,5 Subtle cerebellar signs
may be variably present, but might not be immediately
recognized. Recognition that lithium may be causing the
imbalance is important as this condition is mostly reversible
if the drug is stopped early. However, it may be irreversible if
there are complicating factors such as acute infection with
hyperthermia or concomitant use of neuroleptics.6

Valproate-Related Ataxia
Valproic acid is another drug well known to produce tremor
shortly after starting the drug.7 Reversible parkinsonism and
cognitive impairment are also recognized with a delayed onset
similar to what is seen with lithium.8 Reversible cerebellar
dysfunction that begins with gait ataxia has been seen with
this drug9 anyone with a suspected neurodegenerative disease
that begins while on chronic valproate should be considered
for discontinuation even if (1) the individual has been taking
the drug for years, and (2) the drug levels are in the normal
range. The full improvement may take several months (similar
to tardive dyskinesia); consequently, the slow recovery after
cessation of the valproic acid is still consistent with a cause and
effect relationship and should not be discounted until 6
months after discontinuation of the drug.

Bilateral Vestibular Hypofunction
Bilateral peripheral vestibular loss is an uncommonly recognized cause of imbalance that may be acquired either from
degeneration, sequential bilateral vestibular neuritis, or from
ototoxicity, usually related to gentamicin. It can lead to unsteadiness with few obvious neurologic signs. It can lead to
particularly difﬁcult problems with imbalance in certain subsets of patients with pre-existing somatosensory or visual
impairment. As an example, a diabetic patient with severe
longstanding polyneuropathy from diabetes may receive gentamicin during a hospitalization for infection; after recovery
from the acute illness, the patient seems unable to regain the
ability to maintain balance or walk safely due to vestibular loss.
The combination of vestibular and proprioceptive sensory loss
renders the patient severely off balance despite normal motor
power. Patients may report particular difﬁculty in darkness
(when deprived of vision) and sometimes oscillopsia (perception of “bouncy” vision during locomotion). Examination will
show an abnormal head impulse test in both directions and
severely reduced caloric vestibular responses.15 Bilateral vestibular loss has a reasonably good long-term prognosis for
functional recovery when it is an isolated deﬁcit.16

Tremor and Ataxia

Amiodarone-Related Imbalance

Essential Tremor and Ataxia

Amiodarone is a drug used in the treatment of life-threatening
ventricular arrhythmias. In addition to pulmonary and thyroid
toxicity, neurologic side effects can be seen.10,11 Tremor, parkinsonism, and peripheral neuropathy are the most commonly
reported. Severe, progressive gait ataxia has been reported as
well and appears to be reversible upon stopping the drug.12–14

Essential tremor is a very common neurologic condition
occurring in 5% of those over age 40.17–19 The incidence
increases with age and may be as high as 20% in those over the
age of 80. Gait and balance issues are common in advanced
age; it is often common to simply attribute instability to
aging, in the absence of any other clearly identiﬁed cause.
Seminars in Neurology
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However, it is clear from several studies that some patients
with essential tremor are at a higher risk for developing difﬁculty
walking; therefore, tremor and ataxia may correlate in some
individuals. A study of 36 essential tremor patients and 40 agematched controls demonstrated 50% of patients with essential
tremor had abnormalities of tandem gait compared with 28% of
controls. The abnormality was greater in those older than 70
(N ¼ 22) and those with essential tremor longer than 5 years
(N ¼ 28).20 It was suggested that this ﬁnding was related to the
reports of cerebellar dysfunction seen on blood ﬂow imaging
studies,21 which has been conﬁrmed in other studies subsequently.22,23 Another study followed up on the ﬁndings by
Singer et al to show a similar pattern of gait disturbance. This
study of 25 patients with essential tremor were analyzed with
kinematic analysis and compared with controls and those with
known cerebellar diseases.24 Findings in cases of essential
tremor were similar to those with cerebellar diseases, and
different from controls, with a widening of gait in normal
walking, changes in the heel strike pattern, and distinct problems with the balance of tandem gait. More abnormalities were
seen in those with intention tremor over postural tremor;
duration of disease did not seem to be a factor.
Follow-up studies have further examined the gait of
essential tremor. It seems as though it may be alcohol
responsive with improvement of tandem gait with modest
amount of ethanol compared with worsening of gait in
controls.25 Similarly, functional neurostimulation of the motor nucleus of the thalamus may improve gait in essential
tremor, independent of tremor control.26 These last two
studies taken together suggest that the gait abnormality of
essential tremor may be a functional disturbance rather than
pathologically mediated.

Orthostatic Tremor
Orthostatic tremor does not produce a gait disturbance per se,
but rather a disturbance of stance.27 It is seen in older individuals
(mean age mid-50s) and is characterized clinically by repeated,
irregular buckling of the legs and leg cramps while the patient is
maintaining stance.28 There is often latency of onset of buckling
of up to 3 minutes. Underlying the buckling is a high-frequency
tremor that may be picked up by electromyography, but is
usually not observed because of it ﬁne, rapid nature. Because
of the frequency range of the tremor (13–18 Hz), the tremor
might also be audible with a stethoscope as a low thumping
sound.29 Orthostatic tremor can be seen with parkinsonism in
25% of cases and is associated with essential tremor is some
studies30; however, it is most commonly idiopathic.28 It often
responds to treatment with clonazepam or gabapentin, so this
condition should not be overlooked.31
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linked recessive disorder). The disorder typically begins with
action tremor followed by gait ataxia within 2 to 3 years. With
progression, there may be parkinsonism, dementia, peripheral neuropathy, and autonomic impairment. Magnetic resonance imaging may only show hyperintensity in the middle
cerebellar peduncles. Family history of mental retardation in
cousins and grandchildren may be present. The carrier frequency of the premutation in the general population is
estimated at 1 in 213 for females and 1 in 813 in males.32
Penetrance is age related with 75% of male carriers manifesting symptoms once over 80 years old.33 This makes this
condition similar in prevalence to multiple system atrophy
and amyotrophic lateral sclerosis. It seems to be rare in pure
presentations of various movement disorders. For instance,
the FMR1 premutation is rare to absent in classic essential
tremor and Parkinson’s disease.34,35 However, screening a
cerebellar type of multiple system atrophy and late-onset
cerebellar ataxia in men may produce a positive rate of 5%.36
Based on these types of studies, a review has suggested that
FMR1 premutation screening be performed in cerebellar
ataxia of unknown cause in individuals over the age of 50.37

Other Genetic Ataxias in Late Adulthood
Episodic ataxia type 2 (EA-2) is a genetic disorder that leads to
episodes of dizziness and ataxia. In some patients, there are
no neurologic abnormalities evident between attacks, whereas in others, there is a slowly progressive ataxia that develops
between the attacks characterized by downbeat and or gazeevoked nystagmus and gait ataxia. EA-2 is associated with
more than 20 distinct CACNA1A mutations and the list is
growing.38 SCA 6 is allelic with episodic ataxia 2 (EA-2) and
there appears to be some phenotypic overlap between the
two conditions with some patients initially having an intermittent ataxia before going on to develop a more chronic,
progressive course.39–41 It presents as a relatively pure cerebellar ataxia with gait often affected ﬁrst. Noncerebellar signs
occur less frequently and include decreased vibration/proprioception and impaired upgaze. The frequency of SCA6 is more
common in Japanese and German ataxia families.42 Because
of the older age of onset (mid-50s) and relatively normal life
span, family history may not be immediately obvious; up to
30% of SCA6 may be mislabeled as sporadic ataxia. The
episodic ataxia may be responsive to acetazolamide and
perhaps in some instances 4-aminopyridine.43
The autosomal recessive adult cerebellar ataxias include
late-onset Friedrich’s ataxia and α-tocopherol (vitamin E)
deﬁciency. Both produce an indistinguishable clinical phenotype characterized ataxia with signs of posterior column
involvement, areﬂexia, and extensor plantar responses.44

Fragile X-Associated Tremor/Ataxia
Syndrome

Autoimmune-Mediated Ataxia

Fragile X-associated tremor/ataxia syndrome is a late-onset
neurodegenerative disorder presenting in men over the age
of 50. It occurs in carriers of a premutation range expansion of
the CGG-repeat causative of fragile X mental retardation (X-

It has been recognized for some time that celiac disease may
be associated with neurologic manifestations including sensory neuropathy and ataxia.45 However, in the last 10 to
15 years, it has become clear that these neurologic disorders
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Hashimoto’s Encephalopathy (Autoimmune
Thyroiditis)
Patients with Hashimoto’s encephalopathy present with a
variety of neurologic and psychiatric symptoms including
tremor, confusion, seizures, and psychiatric symptoms. Ataxia has also been reported as a primary manifestation of
autoimmune thyroiditis.55,56 Patients present with a subacute or chronic cerebellar process. There may be a history of
other organ-speciﬁc autoimmune disorders. Imaging may
show cerebellar atrophy in more chronic patients. Laboratory
testing shows elevated levels of antithyroglobulin and antithyroid peroxidase antibodies. Prednisone may result in rapid
improvement in some,56 but not all55 patients. Some patients
may respond to intravenous immunoglobulin.55

Paraneoplastic Disorders
The acute to subacute onset of gait ataxia with normal
imaging should prompt consideration of a paraneoplastic
disorder. Anti-Yo (gynecological cancers and Hodgkin’s lymphoma) and anti-Ri (neuroblastoma) can both produce a
cerebellar disorder.57,58 Anti-Hu (small-cell lung cancer)
can produce a cerebellar ataxia syndrome, usually with
cerebellar examination abnormalities, including ataxic gait,
limb clumsiness, impaired pursuit eye movement tracking,
and gaze-evoked nystagmus. Anti-Hu antibodies may also
result in other paraneoplastic neurologic syndromes including sensory neuronopathy (Denny-Brown syndrome) and
limbic encephalitis.59 Overlap of the various clinical syndromes can be seen such that antibody screening is best
performed more globally unless the underlying cancer is
already known. Onset of the neurologic disorder can precede
the detection of the underlying cancer by months to years in
approximately two-thirds whereas the rest are seen when the
cancer has been treated and may be no longer detectable.

273

Periodic cancer screening should be performed in anyone
with positive antibodies where the cancer was not detectable
on initial evaluation.

Gait Abnormality with Hyperreﬂexia and
Normal Imaging
Adult-Onset Dopa-Responsive Dystonia (Segawa’s
Disease)
Dopa-responsive dystonia is an autosomal dominant dystonia
that usually begins in the ﬁrst decade of life as the child
begins to walk.60,61 Infrequently, however, the onset of
symptoms can occur much later in life,62 resulting in a very
long interval between onset of symptoms and an actual
diagnosis.63 The symptoms consist of gait disturbance categorized by toe walking and sometimes torsion dystonia of the
lower limbs later involving the upper extremities. Over
decades, patients may develop postural tremor and mild
parkinsonian features (except rest tremor). A key feature in
children is the clinical symptoms have marked diurnal variation with exacerbation of symptoms in the evening and often
complete resolution by morning after sleep. Another feature
is that of hyperreﬂexia with ﬂexor plantar reﬂexes, slow
movements, stiffness, and balance difﬁculty.
The most common genetic abnormality seen in doparesponsive dystonia is guanosine triphosphate cyclohydrolase I deﬁciency. With identiﬁcation of a causative gene, other
phenotypes have been identiﬁed including a later age of
onset, a more focal task speciﬁc dystonia or even simple
parkinsonism.64
Onset after the age of 18 seems to be rare, perhaps less
than 10%, but the disorder can be seen as late as the sixth
decade. In addition, the gene has variable penetrance such
that a family history might be absent. Treatment is with
carbidopa/levodopa and the response is typically quite dramatic. Patients remain medication responsive and usually do
not develop motor ﬂuctuations or dyskinesias as with typical
Parkinson’s disease. Often, by the fourth decade, levodopa can
be weaned successfully. Other conditions may mimic doparesponsive dystonia including hereditary spastic paraparesis,
Wilson’s disease, cerebral palsy, and Parkin mutation (youngonset recessive Parkinson’s disease). Because of the unique
sensitivity of this disorder to treatment, a trial of levodopa
should be considered in a patient of any age presenting with a
gait disturbance characterized by lower extremity stiffness
and hyperreﬂexia without causative central nervous system
abnormality on imaging. The peculiar appearance of the gait
may sometimes lead to the erroneous diagnosis of a conversion disorder or psychiatric gait disorder.

Spinal Dural Arteriovenous Fistula
These lesions represent the majority of spinal vascular malformations. The most common clinical presentation is that of
an often ﬂuctuating, progressive myelopathy in middle-aged
men. Clinical signs are due to venous congestion causing cord
compromise. Findings on MRI may be missed or absent on
traditional sequences; magnetic resonance angiography may
be helpful, but neither replaces the need for arteriography.65
Seminars in Neurology
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can present even in the absence of malabsorption or other
gastrointestinal symptoms.46 These patients present with
severe gait ataxia without other cerebellar ﬁndings. Some
have a sensory neuropathy or ganglionopathy.47 Gluten sensitivity may be detected by the presence of antigliadin antibodies (IgA/IgG) and tissues transglutaminase. Intestinal
biopsy may show lymphocytic inﬁltration and changes typical of celiac disease even without classic gastrointestinal
symptoms in 75%.48 Approximately 30% of sporadic ataxia
may show antibodies to gluten compared with 10% of
controls.49–51
What is not entirely clear is whether the antibodies are
causative of ataxia or merely epiphenomena. However, recent
studies have suggested that the gluten sensitivity may be
pathogenic as there are now several reports of the neurologic
condition stabilizing or even improving with strict adherence
to a gluten-free diet.47,52,53 Additionally, treatment with
intravenous immunoglobulin may be of beneﬁt.54 Based on
these studies, it is recommended that patients with sporadic
ataxia and/or progressive sensory ganglionopathy be
screened for antigliadin antibodies. Those positive should
be considered for dietary management. Follow-up with periodic antibody testing is crucial to ensure dietary compliance.
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Findings on traditional MRI may only show subtle T2 hyperintensity (80%); ﬂow voids can usually be seen, but require
especially careful inspection (89%).66 The presence of either of
these two features has a sensitivity of 100% in predicting an
arteriovenous ﬁstula at arteriography or surgery. The identiﬁcation of these lesions is crucial as successful treatment can
stabilize or improve disability.67

14 Willis MS, Lugo AM. Amiodarone-induced neurotoxicity. Am J

Health Syst Pharm 2009;66(6):567–569
15 Hain TC, Cherchi M, Yacovino DA. Bilateral vestibular loss. Semin

Neurol 2013; 33(3)
16 Porciuncula F, Johnson CC, Glickman LB. The effect of vestibular

17

Nutrient and Mineral Malabsorption Syndromes
It should be remembered that in patients with spasticity and
gait difﬁculty with a prior history of bariatric surgery or who
may be prone to short bowel malabsorption, should be
assessed for copper deﬁciency-related myelopathy or vitamin
E or B12 deﬁciency states.68

18

19

20

Conclusion
21

There are many causes of gait ataxia. Many of these can be
identiﬁed based on the presence of additional neurologic
ﬁndings as well as ﬁndings on imaging and neurophysiological studies. When no cause is immediately evident, the
etiology may declare itself over time and close follow-up is
warranted.
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